Acquired cutis laxa

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:228285L98.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acquired cutis laxa (ACL), also known as acquired elastolysis, is a rare connective tissue disorder characterized by loose, redundant, and inelastic skin that gives the affected individual a prematurely aged appearance. Unlike inherited forms of cutis laxa, ACL develops during a person's lifetime rather than being present from birth. The condition results from the destruction or loss of elastic fibers in the skin and potentially other organs. ACL can occur at any age but most commonly presents in adulthood. It may develop following an inflammatory skin condition (such as urticaria, erythema multiforme, or Sweet syndrome), after a severe illness, following drug exposure (such as penicillin or isoniazid), or in association with other systemic diseases including lymphoma, multiple myeloma, or other hematologic disorders. In some cases, no identifiable trigger is found. The skin is the most prominently affected organ, with patients developing pendulous folds of skin, particularly on the face, neck, and trunk, leading to a characteristic aged or hound-dog facial appearance. However, ACL can also involve internal organs. Pulmonary involvement may lead to emphysema and respiratory insufficiency, while cardiovascular complications can include aortic aneurysms, peripheral arterial disease, and cardiac valve abnormalities. Gastrointestinal involvement with diverticula and hernias may also occur. The severity of systemic involvement varies considerably among patients. There is no definitive cure for acquired cutis laxa. Treatment is primarily directed at managing the underlying cause when one is identified, such as treating an associated malignancy or discontinuing an offending medication. Reconstructive or cosmetic surgery may be performed to address the redundant skin, particularly on the face, although results can be variable and skin laxity may recur. Patients with pulmonary or cardiovascular involvement require monitoring and appropriate management of these complications. Dapsone and other anti-inflammatory agents have been tried in some cases with variable success, particularly when an inflammatory process is ongoing.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Acquired cutis laxa.

View clinical trials →

No actively recruiting trials found for Acquired cutis laxa at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Acquired cutis laxa community →

No specialists are currently listed for Acquired cutis laxa.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acquired cutis laxa.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acquired cutis laxaForum →

No community posts yet. Be the first to share your experience with Acquired cutis laxa.

Start the conversation →

Latest news about Acquired cutis laxa

No recent news articles for Acquired cutis laxa.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Acquired cutis laxa

What is Acquired cutis laxa?

Acquired cutis laxa (ACL), also known as acquired elastolysis, is a rare connective tissue disorder characterized by loose, redundant, and inelastic skin that gives the affected individual a prematurely aged appearance. Unlike inherited forms of cutis laxa, ACL develops during a person's lifetime rather than being present from birth. The condition results from the destruction or loss of elastic fibers in the skin and potentially other organs. ACL can occur at any age but most commonly presents in adulthood. It may develop following an inflammatory skin condition (such as urticaria, erythema mu

How is Acquired cutis laxa inherited?

Acquired cutis laxa follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Acquired cutis laxa typically begin?

Typical onset of Acquired cutis laxa is adult. Age of onset can vary across affected individuals.